Systematic analysis of molecular biological mechanisms for supporting connective tissue metabolism with chondroitin sulfate

Nevrologiâ, Nejropsihiatriâ, Psihosomatika

O. A. Gromova¹  I. A. Reier¹  I. Yu. Torshin²  G. I. Nechaeva²  N. V. Zagorodniy³ 

[1] M.V. Lomonosov Moscow State University;Federal Research Center for Informatics and Management, Russian Academy of Sciences;Omsk State Medical University, Ministry of Health of Russia;

关键词: undifferentiated connective tissue dysplasia;    pharmaceutically standardized chondroitin sulfate;    molecular pharmacology;   

DOI  :  10.14412/2074-2711-2021-1-154-162

来源: DOAJ

【 摘 要 】

Objective: to analyze the roles of undifferentiated connective tissue dysplasia (UCTD) in the development of cartilage and ligamentous apparatus diseases.Material and methods. This paper presents the results of analyzing the literature on fundamental and clinical studies of relationships between chondroitin sulfate (CS) and connective tissue (CT) disease. A total of 922 publications on the relationship between CT dysplasia and CS and 2249 publications on CS receptor molecules were analyzed. These arrays of publications were analyzed using topological and metric approaches to data analysis.Results and discussion. The genetic predisposition to UCTD is substantially aggravated by inadequate nutrition that leads to deficiency of certain micronutrients that support CT reconstructive processes. The paper presents the results of a systematic analysis of prospects for the use of drugs based on standardized CS substances in patients with UCTD. CS is a material for CT reconstruction. CS increases the activity of growth factors and reduces CT inflammatory destruction (inhibition of the secretion of histamine, pro-inflammatory chemokines, Toll-like receptors, and the NF-κB cascade through exposure to the CD44 receptor).Conclusion. The pharmacological effects of CS indicate the importance of using standardized CS forms in the treatment of patients with UCTD.

【 授权许可】

Unknown